4D Molecular Therapeutics Chief Legal Officer Scott Bizily Reports Sale of $20,993.40 in Common Shares

By Public Technologies
  • 4D Molecular Therapeutics Chief Legal Officer Scott Bizily sold 1,635 common shares at $12.84 each on Oct. 16, 2026.
  • Bizily exercised stock options for 1,635 common shares at $4.14 each that day.
  • Following the transactions, he directly owned 8,617 common shares and held 56,431 stock options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-426810), on October 20, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk